Tom J Galloway

15PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisRehabilitationRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 06, 2026
The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer: Results from the NRG/RTOG 1016 Trial.

Joanne B Weidhaas, Jonathan Harris, Maura L Gillison

|May 09, 2025
Paranasal Sinus and Nasal Cavity Cancers: Systematic Review and Executive Summary of the American Radium Society Appropriate Use Criteria.

Matthew E Witek, Matthew C Ward, Richard Bakst

|Dec 10, 2024
Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer.

Li Guan, Pedro A Torres-Saavedra, Xiaobei Zhao

|Jun 12, 2024
Timing of postoperative radiation therapy for major salivary gland cancers.

Flora Yan, Jeffrey C Liu, Rebecca Shulman

|Mar 21, 2023
Benefits versus drawbacks of delaying surgery due to additional consultations in older patients with breast cancer.

Brian L Egleston, Richard J Bleicher, Carolyn Y Fang

|May 13, 2022
Assessing plasma circulating tumor human papillomavirus (HPV) DNA in determining treatment response in HPV-associated oropharyngeal cancer.

Kevin K Zarrabi, Thomas J Galloway, Douglas B Flieder

Pageof 3

Frequent Collaborators

4 joint publications

Sue S Yom

4 joint publications

Jeffrey C Liu

4 joint publications

Jessica R Bauman

3 joint publications

Danielle N Margalit